Asco Annual Meeting 2024 Full Proceedings. Phase i/iia umbrella trial of molecularly matched targeted therapies plus radiotherapy in patients with newly diagnosed glioblastoma without mgmt promoter hypermethylation. Stay informed on the latest advancements and breakthroughs in cancer research and treatment.
It is intended for healthcare professionals outside the united kingdom (uk) and australia. Asco offers premier scientific events for oncology professionals, patient advocates, industry representatives, and major media outlets worldwide.
Asco Annual Meeting 2024 Full Proceedings Images References :